Article
An Intronic HCP5 Variant Is Associated With Age of Onset and Susceptibility to Graves Disease in UK and Polish Cohorts.
The Journal of clinical endocrinology and metabolism - 1 Sept 2020
Lane Laura Claire, Kuś Aleksander, Bednarczuk Tomasz, Bossowski Artur, Daroszewski Jacek, Jurecka-Lubieniecka Beata, Cordell Heather Jane, Pearce Simon Henry Schofield, Cheetham Timothy, Mitchell Anna Louise
Abstract excerpt
CONTEXT: The genetic background of young-onset Graves disease (GD) remains largely unknown. An intronic variant in human leukocyte antigen (HLA) complex P5 (HCP5) has previously been associated with GD susceptibility and age of onset in a cohort of Polish patients. OBJECTIVE: We aimed to investigate the association of the HCP5 variant rs3094228 with GD susceptibility and age of onset in a UK cohort and conduct a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
